Myriad Genetics
MYGN
MYGN
267 hedge funds and large institutions have $2.62B invested in Myriad Genetics in 2013 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 125 increasing their positions, 73 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
39% less call options, than puts
Call options by funds: $58.2M | Put options by funds: $95.6M
Holders
267
Holding in Top 10
2
Calls
$58.2M
Puts
$95.6M
Top Buyers
| 1 | +$86.1M | |
| 2 | +$71.3M | |
| 3 | +$71.2M | |
| 4 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$37.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$26.2M |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$16.1M | |
| 3 | -$14.5M | |
| 4 |
JCI
Jet Capital Investors
New York
|
-$13.6M |
| 5 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$11.2M |